By
The Wire Science
Published: Nov. 29, 2020, 4:42 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access
New Delhi: A Government of India drugs advisory committee has approved the use of Johnson & Johnson’s (J&J) bedaquiline – used to treat tuberculosis (TB) – for minor patients in the country without conducting any local clinical trials first.
Read More →